Skip to main content
RLAY filings

Corporate insider profile

Donald A Bergstrom Filing Activity

Latest reported as President, R&D of Relay Therapeutics, Inc. (RLAY).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,605,181.74
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026Relay Therapeutics, Inc. (RLAY)President, R&DSale93,456$16.94$1,583,145
Apr 28, 2026Relay Therapeutics, Inc. (RLAY)President, R&DSale1,490$14.79$22,037